These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 23327881

  • 21. Efficacy and safety of tacrolimus for induction therapy in patients with active lupus nephritis.
    Takahashi S, Hiromura K, Sakurai N, Matsumoto T, Ikeuchi H, Maeshima A, Kaneko Y, Kuroiwa T, Nojima Y.
    Mod Rheumatol; 2011 Jun; 21(3):282-9. PubMed ID: 21188448
    [Abstract] [Full Text] [Related]

  • 22. Tacrolimus is an alternative therapeutic option for the treatment of refractory lupus nephritis.
    Lee T, Oh KH, Joo KW, Kim YS, Ahn C, Han JS, Kim S, Chin HJ.
    Lupus; 2010 Jul; 19(8):974-80. PubMed ID: 20581020
    [Abstract] [Full Text] [Related]

  • 23. Efficacy and safety of multitarget therapy with cyclophosphamide and tacrolimus for lupus nephritis: a prospective, single-arm, single-centre, open label pilot study in Japan.
    Sakai R, Kurasawa T, Nishi E, Kondo T, Okada Y, Shibata A, Nishimura K, Chino K, Okuyama A, Takei H, Nagasawa H, Amano K.
    Lupus; 2018 Feb; 27(2):273-282. PubMed ID: 28683654
    [Abstract] [Full Text] [Related]

  • 24. Efficacy and safety of tacrolimus for lupus nephritis: a placebo-controlled double-blind multicenter study.
    Miyasaka N, Kawai S, Hashimoto H.
    Mod Rheumatol; 2009 Feb; 19(6):606-15. PubMed ID: 19688181
    [Abstract] [Full Text] [Related]

  • 25. Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial.
    Houssiau FA, Vasconcelos C, D'Cruz D, Sebastiani GD, de Ramon Garrido E, Danieli MG, Abramovicz D, Blockmans D, Mathieu A, Direskeneli H, Galeazzi M, Gül A, Levy Y, Petera P, Popovic R, Petrovic R, Sinico RA, Cattaneo R, Font J, Depresseux G, Cosyns JP, Cervera R.
    Arthritis Rheum; 2004 Dec; 50(12):3934-40. PubMed ID: 15593207
    [Abstract] [Full Text] [Related]

  • 26. Effects of cyclosporine A on serum and urinary soluble interleukin-2 receptor in patients with lupus nephritis.
    Tang Z, Zhang J, Zhang S, Li L.
    Chin Med J (Engl); 1997 Sep; 110(9):686-9. PubMed ID: 9642325
    [Abstract] [Full Text] [Related]

  • 27. Tacrolimus for the treatment of systemic lupus erythematosus with pure class V nephritis.
    Szeto CC, Kwan BC, Lai FM, Tam LS, Li EK, Chow KM, Gang W, Li PK.
    Rheumatology (Oxford); 2008 Nov; 47(11):1678-81. PubMed ID: 18753192
    [Abstract] [Full Text] [Related]

  • 28. Long-term follow-up of a randomised controlled trial of azathioprine/methylprednisolone versus cyclophosphamide in patients with proliferative lupus nephritis.
    Arends S, Grootscholten C, Derksen RH, Berger SP, de Sévaux RG, Voskuyl AE, Bijl M, Berden JH, Dutch Working Party on systemic lupus erythematosus.
    Ann Rheum Dis; 2012 Jun; 71(6):966-73. PubMed ID: 22128082
    [Abstract] [Full Text] [Related]

  • 29. Efficacy and safety of multi-target therapy using a combination of tacrolimus, mycophenolate mofetil and a steroid in patients with active lupus nephritis.
    Ikeuchi H, Hiromura K, Takahashi S, Mishima K, Sakurai N, Sakairi T, Kaneko Y, Maeshima A, Kuroiwa T, Nojima Y.
    Mod Rheumatol; 2014 Jul; 24(4):618-25. PubMed ID: 24252014
    [Abstract] [Full Text] [Related]

  • 30. Implication of the peak serum level of mizoribine for control of the serum anti-dsDNA antibody titer in patients with lupus nephritis.
    Tanaka H, Tsugawa K, Nakahata T, Kudo M, Suzuki K, Ito E.
    Clin Nephrol; 2005 Jun; 63(6):417-22. PubMed ID: 15960142
    [Abstract] [Full Text] [Related]

  • 31. Long-term follow-up in lupus nephritis patients treated with rituximab--clinical and histopathological response.
    Jónsdóttir T, Zickert A, Sundelin B, Henriksson EW, van Vollenhoven RF, Gunnarsson I.
    Rheumatology (Oxford); 2013 May; 52(5):847-55. PubMed ID: 23287364
    [Abstract] [Full Text] [Related]

  • 32. Safety of tacrolimus in patients with rheumatoid arthritis: long-term experience.
    Yocum DE, Furst DE, Bensen WG, Burch FX, Borton MA, Mengle-Gaw LJ, Schwartz BD, Wisememandle W, Mekki QA, Tacrolimus RA Study Group.
    Rheumatology (Oxford); 2004 Aug; 43(8):992-9. PubMed ID: 15014199
    [Abstract] [Full Text] [Related]

  • 33. Effects of long-term treatment with mizoribine in patients with proliferative lupus nephritis.
    Yumura W, Suganuma S, Uchida K, Moriyama T, Otsubo S, Takei T, Naito M, Koike M, Nitta K, Nihei H.
    Clin Nephrol; 2005 Jul; 64(1):28-34. PubMed ID: 16047642
    [Abstract] [Full Text] [Related]

  • 34. A switch from conventional twice-daily tacrolimus to once-daily extended-release tacrolimus in stable kidney transplant recipients.
    Hatakeyama S, Fujita T, Yoneyama T, Yoneyama T, Koie T, Hashimoto Y, Saitoh H, Funyu T, Narumi S, Ohyama C.
    Transplant Proc; 2012 Jan; 44(1):121-3. PubMed ID: 22310594
    [Abstract] [Full Text] [Related]

  • 35. Long-term outcomes--mycophenolate mofetil treatment for lupus nephritis with addition of tacrolimus for resistant cases.
    Cortés-Hernández J, Torres-Salido MT, Medrano AS, Tarrés MV, Ordi-Ros J.
    Nephrol Dial Transplant; 2010 Dec; 25(12):3939-48. PubMed ID: 20538787
    [Abstract] [Full Text] [Related]

  • 36. Comparison of efficacy of continuous mycophenolate mofetil with sequential cyclophosphamide and tacrolimus as maintenance therapy for lupus nephritis.
    Kawazoe M, Nanki T.
    Lupus; 2024 Apr; 33(4):319-327. PubMed ID: 38232223
    [Abstract] [Full Text] [Related]

  • 37. Mizoribine, tacrolimus, and corticosteroid combination therapy successfully induces remission in patients with lupus nephritis.
    Kagawa H, Hiromasa T, Hara T, Takaki A, Yamanaka R, Sada KE, Makino H.
    Clin Exp Nephrol; 2012 Oct; 16(5):760-6. PubMed ID: 22492013
    [Abstract] [Full Text] [Related]

  • 38. Cyclosporine for the treatment of lupus nephritis in patients with systemic lupus erythematosus.
    Yang TH, Wu TH, Chang YL, Liao HT, Hsu CC, Tsai CY, Chou YC.
    Clin Nephrol; 2018 Apr; 89(4):277-285. PubMed ID: 29319493
    [Abstract] [Full Text] [Related]

  • 39. Mizoribine oral pulse therapy for patients with disease flare of lupus nephritis.
    Tanaka H, Suzuki K, Nakahata T, Tsugawa K, Ito E, Waga S.
    Clin Nephrol; 2003 Dec; 60(6):390-4. PubMed ID: 14690255
    [Abstract] [Full Text] [Related]

  • 40. [Evaluation of serum C3 and CH50 levels as markers of disease-activity and indicators of efficacy of treatment of lupus nephritis in childhood].
    Ibe M, Kuriyama T, Mori M, Mitsuda T, Aihara Y, Yokota S.
    Ryumachi; 1994 Aug; 34(4):715-24. PubMed ID: 7974022
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.